bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
0.3068
-0.0032 (-1.03%)
At close: Jul 11, 2025, 4:00 PM
0.3129
+0.0061 (1.99%)
After-hours: Jul 11, 2025, 6:39 PM EDT
bioAffinity Technologies Market Cap
bioAffinity Technologies has a market cap or net worth of $8.45 million as of July 11, 2025. Its market cap has decreased by -62.26% in one year.
Market Cap
8.45M
Enterprise Value
9.33M
1-Year Change
-62.26%
Ranking
Category
Stock Price
$0.31
Market Cap Chart
Since the IPO on September 1, 2022, bioAffinity Technologies's market cap has decreased from $45.03M to $8.45M, a decrease of -81.24%. That is a compound annual growth rate of -44.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 8.45M | -40.45% |
| Dec 31, 2024 | 14.18M | 1.50% |
| Dec 29, 2023 | 13.97M | 4.34% |
| Dec 30, 2022 | 13.39M | -70.26% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.91B |
| Johnson & Johnson | 377.51B |
| AbbVie | 339.94B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 275.86B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 229.69B |
| AstraZeneca | 218.74B |